tiprankstipranks
Trending News
More News >
Esperion Therapeutics (ESPR)
NASDAQ:ESPR

Esperion (ESPR) Revenue

Compare
1,637 Followers

Esperion Revenue

Esperion had a revenue of 87.31M in the quarter ending Sep 30, 2025, with 5.98%. This bring the company's revenue in the last twelve months to 303.80M, Decreased 13.31%. In the fiscal year ending Dec 31, 2024, Esperion had annual revenue of 332.31M with 185.66% growth.
Revenue (ttm)
303.80M
Revenue Growth
2.83%
P/S Ratio
2.83
Revenue/Employee
$1,093,138
Employees
304
Market Cap
$939.52M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
332.31M215.98M+285.66%
Dec 31, 2023
116.33M40.86M+154.14%
Dec 31, 2022
75.47M-2.97M+96.21%
Dec 31, 2021
78.45M-149.10M+34.48%
Dec 31, 2020
227.55M79.18M+153.37%
Dec 31, 2019
148.36M-36.11M+80.43%
Dec 31, 2018
184.47M-18,447,400,000.00%
Dec 31, 2017
Dec 31, 2016